CoLucid Pharmaceuticals, Inc. CLCD was a big mover last session, as the company saw its shares rise roughly 10% on the day. The move came on solid volume too with far more shares changing hands than ...

CoLucid Pharmaceuticals Inc CLCD has been on the move lately as the stock has risen by 29.9% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move ...

Towards the end of August, we published this piece detailing two major potential upside catalysts to keep an eye on early September. One of the companies we profiled was CoLucid Pharmaceuticals Inc ...

One stock that might be an intriguing choice for investors right now is CoLucid Pharmaceuticals, Inc. CLCD. This is because this security in the Medical – Biomedical and Genetics space is seeing solid ...

The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research ...

On Wednesday, shares of biopharmaceutical company CoLucid Pharmaceuticals CLCD are skyrocketing, up around 32% in midday trading after Eli Lilly and Co. announced it is buying the company for a ...

CoLucid Pharmaceuticals, Inc.CLCD has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because CLCD is now in overbought territory with an RSI ...

Colucid Pharmaceuticals Inc (NASDAQ: CLCD) is acting great. It popped 1.60, or 4%, to 40.10, on 251,610 shares traded. It's right up against key resistance. The prior high was 40.50, and on Monday the ...

As of late, it has definitely been a great time to be an investor in CoLucid Pharmaceuticals Inc CLCD. The stock has moved higher by 39.4% in the past month, while it is also above its 20 Day SMA too.